Literature DB >> 22130640

Viruses and multiple sclerosis.

Gregory P Owens1, Don Gilden, Mark P Burgoon, Xiaoli Yu, Jeffrey L Bennett.   

Abstract

Multiple sclerosis (MS) is a chronic demyelinating disorder of unknown etiology, possibly caused by a virus or virus-triggered immunopathology. The virus might reactivate after years of latency and lyse oligodendrocytes, as in progressive multifocal leukoencephalopathy, or initiate immunopathological demyelination, as in animals infected with Theiler's murine encephalomyelitis virus or coronaviruses. The argument for a viral cause of MS is supported by epidemiological analyses and studies of MS in identical twins, indicating that disease is acquired. However, the most important evidence is the presence of bands of oligoclonal IgG (OCBs) in MS brain and CSF that persist throughout the lifetime of the patient. OCBs are found almost exclusively in infectious CNS disorders, and antigenic targets of OCBs represent the agent that causes disease. Here, the authors review past attempts to identify an infectious agent in MS brain cells and discuss the promise of using recombinant antibodies generated from clonally expanded plasma cells in brain and CSF to identify disease-relevant antigens. They show how this strategy has been used successfully to analyze antigen specificity in subacute sclerosing panencephalitis, a chronic encephalitis caused by measles virus, and in neuromyelitis optica, a chronic autoimmune demyelinating disease produced by antibodies directed against the aquaporin-4 water channel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130640      PMCID: PMC3293404          DOI: 10.1177/1073858411386615

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  101 in total

1.  Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts.

Authors:  Kimberly M Winges; Donald H Gilden; Jeffrey L Bennett; Xiaoli Yu; Alanna M Ritchie; Gregory P Owens
Journal:  J Neuroimmunol       Date:  2007-11-13       Impact factor: 3.478

2.  VH4 gene segments dominate the intrathecal humoral immune response in multiple sclerosis.

Authors:  Gregory P Owens; Kimberly M Winges; Alanna M Ritchie; Sydni Edwards; Mark P Burgoon; Laura Lehnhoff; Kirsten Nielsen; John Corboy; Donald H Gilden; Jeffrey L Bennett
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

3.  Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

Authors:  Birgit Obermeier; Reinhard Mentele; Joachim Malotka; Josef Kellermann; Tania Kümpfel; Hartmut Wekerle; Friedrich Lottspeich; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

4.  Accurate identification of paraprotein antigen targets by epitope reconstruction.

Authors:  Seshi R Sompuram; Gerassimos Bastas; Kodela Vani; Steven A Bogen
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

5.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Authors:  Stephen L Hauser; Emmanuelle Waubant; Douglas L Arnold; Timothy Vollmer; Jack Antel; Robert J Fox; Amit Bar-Or; Michael Panzara; Neena Sarkar; Sunil Agarwal; Annette Langer-Gould; Craig H Smith
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

6.  Homogeneity of active demyelinating lesions in established multiple sclerosis.

Authors:  Esther C W Breij; Bianca P Brink; Rob Veerhuis; Christa van den Berg; Rianka Vloet; Riqiang Yan; Christine D Dijkstra; Paul van der Valk; Lars Bö
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

7.  Characterization of phage peptide interaction with antibody using phage mediated immuno-PCR.

Authors:  Xiaoli Yu; Mark P Burgoon; Andrew J Shearer; Donald H Gilden
Journal:  J Immunol Methods       Date:  2007-07-18       Impact factor: 2.303

8.  Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF.

Authors:  G P Owens; A M Ritchie; D H Gilden; M P Burgoon; D Becker; J L Bennett
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

9.  Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis.

Authors:  Julio Sotelo; Adolfo Martínez-Palomo; Graciela Ordoñez; Benjamin Pineda
Journal:  Ann Neurol       Date:  2008-03       Impact factor: 10.422

10.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.

Authors:  Barbara Serafini; Barbara Rosicarelli; Diego Franciotta; Roberta Magliozzi; Richard Reynolds; Paola Cinque; Laura Andreoni; Pankaj Trivedi; Marco Salvetti; Alberto Faggioni; Francesca Aloisi
Journal:  J Exp Med       Date:  2007-11-05       Impact factor: 14.307

View more
  30 in total

Review 1.  Multiple sclerosis: autoimmunity and viruses.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

2.  Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.

Authors:  Nicholas E Martinez; Fumitaka Sato; Eiichiro Kawai; Seiichi Omura; Satoru Takahashi; Keigyou Yoh; Ikuo Tsunoda
Journal:  Brain Behav Immun       Date:  2014-07-18       Impact factor: 7.217

3.  Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.

Authors:  Simone M Brändle; Birgit Obermeier; Makbule Senel; Jessica Bruder; Reinhard Mentele; Mohsen Khademi; Tomas Olsson; Hayrettin Tumani; Wolfgang Kristoferitsch; Friedrich Lottspeich; Hartmut Wekerle; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

4.  Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands.

Authors:  Gijsbert P van Nierop; Rogier Q Hintzen; Georges M G M Verjans
Journal:  J Neurovirol       Date:  2014-03-27       Impact factor: 2.643

5.  [Multiple sclerosis and microbiota. From genome to metagenome?].

Authors:  R Hohlfeld; H Wekerle
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

Review 6.  Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Nikolaos Grigoriadis; Efthimia Petinaki; Georgios M Hadjigeorgiou
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

Review 7.  Toll-like receptors in mediating pathogenesis in systemic sclerosis.

Authors:  L Frasca; R Lande
Journal:  Clin Exp Immunol       Date:  2020-02-21       Impact factor: 4.330

Review 8.  The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.

Authors:  Giulia Mallucci; Luca Peruzzotti-Jametti; Joshua D Bernstock; Stefano Pluchino
Journal:  Prog Neurobiol       Date:  2015-03-21       Impact factor: 11.685

9.  Genomic analysis of ERVWE2 locus in patients with multiple sclerosis: absence of genetic association but potential role of human endogenous retrovirus type W elements in molecular mimicry with myelin antigen.

Authors:  Guilherme S do Olival; Thiago S Faria; Luiz H S Nali; Augusto C P de Oliveira; Jorge Casseb; Jose E Vidal; Vitor B Cavenaghi; Charles P Tilbery; Lenira Moraes; Maria C S Fink; Laura M Sumita; Hervé Perron; Camila M Romano
Journal:  Front Microbiol       Date:  2013-06-26       Impact factor: 5.640

10.  Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.

Authors:  Mohsen Foroughipour; Fatemeh Behdani; Paria Hebrani; Majid Nabizadeh Marvast; Fereshte Esmatinia; Amir Akhavanrezayat
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.